NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/02/2024
Back to search
Official data from USPTO
DR. KHARRAZIAN'S 3D IMMUNE TOLERANCE PROGRAM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
DR. KHARRAZIAN'S 3D IMMUNE TOLERANCE PROGRAM
ST13
US500000090791054Class
41
Filing
90791054
Registration
7264295
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
01/02/2024
Trademark type
Word
Nice classes
41
Filing date
06/23/2021
Registration date
01/02/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/02/2024
Last transaction
01/02/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
First use anywhere
08/20/2020
First use in commerce
08/20/2020
Drawing code
4
Owner type
01
Owner location
Carlsbad, CA
Examiner
SORIANO, JASMINE
Law office
O20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Kharrazian, Datis
Representatives
Eric D. Morton CLEAR SKY LAW GROUP, P.C.
Technical classification
Nice Classes
Class 41
Vienna Codes
No Vienna codes available.
Goods and services
Class 41
Educational servicesproviding onlinenon-downloadable videos and written materials in the nature of articlesblog postsnewslettersworkbooksbooks to teach a program of dietnutritionlifestyle principles in the fields of immune system support and immune tolerance and distribution of written course materials in connection therewith in printed or electronic format
Publications
History of USPTO decisions and trademark events.
29 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
01/02/2024
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
05/03/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
05/02/2023
GNFR
FINAL REFUSAL E-MAILED
05/02/2023
CNFR
FINAL REFUSAL WRITTEN
05/02/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/10/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/08/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/08/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/09/2023
GNRT
NON-FINAL ACTION E-MAILED
01/09/2023
CNRT
NON-FINAL ACTION WRITTEN
01/09/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/07/2022
GNRT
NON-FINAL ACTION E-MAILED
12/07/2022
CNRT
NON-FINAL ACTION WRITTEN
12/07/2022
RFTP
REMOVED FROM TEAS PLUS
12/07/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
11/09/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/09/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
11/09/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/09/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/06/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/05/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/05/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/07/2022
GNRT
NON-FINAL ACTION E-MAILED
04/07/2022
CNRT
NON-FINAL ACTION WRITTEN
04/07/2022
DOCK
ASSIGNED TO EXAMINER
03/14/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/08/2021
NWAP
NEW APPLICATION ENTERED
06/26/2021
Continuous trademark protection
Get notified about every new filing that threatens DR. KHARRAZIAN'S 3D IMMUNE TOLERANCE PROGRAM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.